Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir-based regimens in genotype 2 or 3 chronic HCV infection
2013-002641-11Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Aug 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of sofosbuvir in hepatitis C virus infection (3 arms), sponsored by Gilead Sciences. Primary endpoint: SVR12. Started Aug 2013; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2013-002641-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002641-11.